google-site-verification: googlec7193c3de77668c9.html

Tag Archives: Three

FDA approves SetPoint neuroimmune modulation device for rheumatoid arthritis

[ The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The SetPoint System is indicated for patients who are not adequately managed by—or cannot tolerate—existing advanced RA therapies, such as biological and targeted …

Read More »

Recent Comments